California Public Employees Retirement System’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-127,435
Closed -$2.85M 1165
2024
Q2
$2.85M Buy
127,435
+811
+0.6% +$19.3K ﹤0.01% 1131
2024
Q1
$3.48M Hold
126,624
﹤0.01% 1133
2023
Q4
$3.86M Hold
126,624
﹤0.01% 1129
2023
Q3
$4M Hold
126,624
﹤0.01% 1114
2023
Q2
$5.16M Hold
126,624
﹤0.01% 1069
2023
Q1
$4.72M Sell
126,624
-19,964
-14% -$783K ﹤0.01% 1093
2022
Q4
$5.11M Sell
146,588
-10,409
-7% -$495K ﹤0.01% 1104
2022
Q3
$8.79M Buy
156,997
+37,062
+31% +$2.3M 0.01% 931
2022
Q2
$6.21M Sell
119,935
-28,766
-19% -$1.46M 0.01% 1029
2022
Q1
$10.8M Sell
148,701
-4,885
-3% -$414K 0.01% 893
2021
Q4
$18.2M Buy
153,586
+702
+0.5% +$87.9K 0.01% 703
2021
Q3
$20.5M Buy
152,884
+9,125
+6% +$1.38M 0.02% 653
2021
Q2
$23.3M Buy
143,759
+2,657
+2% +$207K 0.02% 626
2021
Q1
$11.3M Buy
141,102
+26,868
+24% +$1.8M 0.01% 1001
2020
Q4
$6.21M Buy
114,234
+852
+0.8% +$30.9K ﹤0.01% 1302
2020
Q3
$2.25M Buy
113,382
+24,682
+28% +$515K ﹤0.01% 1769
2020
Q2
$1.86M Buy
88,700
+9,900
+13% +$168K ﹤0.01% 1838
2020
Q1
$964K Buy
78,800
+12,500
+19% +$168K ﹤0.01% 2036
2019
Q4
$973K Buy
66,300
+54,900
+482% +$764K ﹤0.01% 2383
2019
Q3
$152K Buy
+11,400
New +$182K ﹤0.01% 3007
2018
Q3
Sell
-10,638
Closed -$291K 3296
2018
Q2
$291K Buy
+10,638
New +$258K ﹤0.01% 2865

Other funds holding NTLA

California Public Employees Retirement System's NTLA Position: Q3 2024 in Review

California Public Employees Retirement System sold out of Intellia Therapeutics (NTLA) in Q3 2024, closing a stake of 127,435 shares — an estimated $2.85M sold.

California Public Employees Retirement System first reported a position in NTLA in Q2 2018 and held it in 21 quarters. The position peaked at $23.3M in Q2 2021. 284 funds tracked by Wall St. Rank hold NTLA as of Q3 2024.

  • California Public Employees Retirement System reported no remaining Intellia Therapeutics position as of Q3 2024 after selling out during the quarter.
  • California Public Employees Retirement System sold 127,435 Intellia Therapeutics shares in Q3 2024, an estimated $2.85M.
  • California Public Employees Retirement System first reported a position in Intellia Therapeutics in Q2 2018 and held it in 21 quarters.
  • California Public Employees Retirement System's Intellia Therapeutics position peaked at $23.3M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2024.

Based on California Public Employees Retirement System's 13F filing for Q3 2024, filed 13 Nov 2024.